Genomics provide hope for those with “one in a million” cancer diagnosis

Genetic tumour profiling provides new information for more than 1 in 2  

New research has shown that many Australians with rare cancers can benefit from genomic profilingThe findings of the patient-driven trial are being presented today at the Clinical Oncology Society of Australia Annual Scientific Meeting and could result in dramatic changes to the way those with rare cancers are diagnosed and treated.